DERM vs TAP
Journey Medical Corp (DERM) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
TAP (TAP) common stock.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
TAP does not have a complete income-statement cache yet.
DERM currently screens at market cap $163.1M. TAP currently screens at market cap $0.
Not investment advice. Open the DERM and TAP stock pages for the full models.
Not investment advice.